Lawyers to Meet Next Week on Merck&#39;s Vioxx -NYT
157796
Drugs giant Merck &amp; Co. which pulled its blockbuster painkiller Vioxx from shelves in September, is about to become the target of hundreds of plaintiffs&#39; lawyers, the New York Times reported on Friday.
22491
Raymond Gilmartin, chief executive of Merck, will testify before a Senate committee this week on the withdrawal of Vioxx, in spite of efforts by the drug company to send others in his place.
623702
Beleaguered pharmaceutical giant Merck &amp; Co. Inc. has appointed a special committee of board members and a retired federal judge to review the company&#39;s actions before it
679017
A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the market and losing a quarter of its stock market value as a result, Merck &amp; Co. will try to dodge the storm clouds and turn its attention tomorrow to a brighter subject with the official opening of its Boston research lab.
23664
Merck &amp; Co. Inc. Chief Executive Officer Raymond Gilmartin and FDA officials have been called to testify before Congress on Nov. 18 over safety problems with the company&#39;s withdrawn
565909
More than 3,000 former users of Merck & Co's  withdrawn Vioxx pain drug have already signed up to take part in a $4.85 billion settlement deal that a federal judge said on Friday was in the best interests of both sides.
485027
Drug maker Merck &amp; Co. reported Tuesday that its board appointed a special committee to review the company&#39;s actions before withdrawing blockbuster arthritis drug Vioxx from the market Sept.
207032
A proposed $4.85 billion pact between Merck & Co Inc and users of painkiller Vioxx would force plaintiffs' lawyers to make recommendations to clients that may not be in their best interests, according to attorneys who are challenging the pact's terms.
91514
A veteran U.S. Food and Drug  Administration scientist will unveil new data on Thursday  before an expert panel charged with determining whether pain  relievers similar to Merck & Co. Inc.'s now-withdrawn Vioxx  should remain on the market.
254339
Drug maker Merck & Co. Inc. on  Tuesday said its board appointed a committee to review the  company's actions prior to the voluntary withdrawal of its  painkiller Vioxx.
443780
News events to watch for in the coming week.
184939
U.S. Food and Drug Administration  Acting Commissioner Lester Crawford on Friday agreed to meet  with a top Republican lawmaker about the agency's handling of  safety concerns over Merck & Co Inc.'s now-withdrawn painkiller  Vioxx.
105898
Merck &amp; Co. officials said Tuesday they intend to defend aggressively their handling of the painkiller Vioxx against claims by patients who say they were harmed by the now-withdrawn drug.
478691
Merck&#39;s board of directors yesterday formed a special committee to review the drug maker&#39;s handling of the controversial painkiller Vioxx.
510588
BOSTON (CBS.MW) -- Pharmaceutical behemoth Merck heads to Capitol Hill Thursday to testify at a Senate hearing on whether the government should have forced the drugmaker to withdraw its Vioxx drug from the market before late September.
236746
A month after Merck quit selling Vioxx in the face of new evidence that its blockbuster painkiller caused heart attacks, strokes and other serious ailments, the company and plaintiffsâ lawyers are scrambling to adjust to a surge in related lawsuits.
158316
Amid questions about whether the arthritis drug Vioxx was taken off the market soon enough, a key senator suggested Friday that an independent board of drug safety might